Achira aims to bring sophisticated medical tests closer to the point of diagnosis...
HPV primary testing without the need for a traditional Pap smear performed with a speculum...
For managing chronic diseases and shaping future medical practices...
Beckman Coulter now an authorised distributor of MeMed key immunoassay system and MeMed BV assay...
To contribute to the advancement of genomics in Latin America...
Advanced tests based on a genomic analysis pipeline specifically developed and validated on Indian samples and conditions ...
Offers faster testing, early risk identification, thereby improving disease management...
New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs...
In a groundbreaking initiative, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd have joined forces in a Contract Development and Manufacturing Organization (CDMO) collaboration focused on advancing Cartridge-based CLIA system reagents....
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company...
